We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-14.79%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$96.1B
AUM Growth
-$20.7B
Cap. Flow
-$1.83B
Cap. Flow %
-1.91%
Top 10 Hldgs %
18.42%
Holding
4,634
New
1,015
Increased
1,222
Reduced
1,970
Closed
108

Top Sells

Rank Stock Value
1
FXI icon
iShares China Large-Cap ETF
FXI
+$256M
2
C icon
Citigroup
C
+$159M
3
PCG icon
PG&E
PCG
+$138M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$132M
5
UBS icon
UBS Group
UBS
+$113M

Sector Composition

Rank Sector Weight
1 Technology 21.62%
2 Healthcare 16.32%
3 Financials 13.63%
4 Consumer Discretionary 9.13%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTMD icon
4176
Utah Medical Products
UTMD
$230M
$0 ﹤0.01%
+8
New +$682
UXIN
4177
Uxin Ltd
UXIN
$275M
$0 ﹤0.01%
1
-250
-100% -$15K
VALU icon
4178
Value Line
VALU
$331M
$0 ﹤0.01%
+4
New +$274
VATE icon
4179
INNOVATE Corp
VATE
$106M
$0 ﹤0.01%
+3
New +$82
VEL icon
4180
Velocity Financial
VEL
$700M
$0 ﹤0.01%
+45
New +$478
VEON icon
4181
VEON
VEON
$3.76B
-8,955
Closed -$153K
VFF icon
4182
Village Farms International
VFF
$242M
$0 ﹤0.01%
+15
New +$54
VGZ icon
4183
Vista Gold
VGZ
$270M
$0 ﹤0.01%
+5
New +$4
VHC icon
4184
VirnetX Holding Corp
VHC
$56.8M
$0 ﹤0.01%
+2
New +$56
VHI icon
4185
Valhi
VHI
$388M
$0 ﹤0.01%
+11
New +$438
VIGL
4186
DELISTED
Vigil Neuroscience
VIGL
$0 ﹤0.01%
+4
New +$16
VKTX icon
4187
Viking Therapeutics
VKTX
$3.84B
$0 ﹤0.01%
36
-49,098
-100% -$122K
VLGEA icon
4188
Village Super Market
VLGEA
$656M
$0 ﹤0.01%
+9
New +$212
VLO icon
4189
CALL
Valero Energy
VLO
$88.9B
-31,200
Closed -$3.17M
VMD icon
4190
Viemed Healthcare
VMD
$377M
$0 ﹤0.01%
+19
New +$102
VOR icon
4191
Vor Biopharma
VOR
$1.21B
$0 ﹤0.01%
+1
New +$102
VRA icon
4192
Vera Bradley
VRA
$99M
$0 ﹤0.01%
+14
New +$85
VRCA icon
4193
Verrica Pharmaceuticals
VRCA
$92.9M
$0 ﹤0.01%
+1
New +$50
VSEC icon
4194
VSE Corp
VSEC
$6.01B
$0 ﹤0.01%
+11
New +$432
VTGN icon
4195
VistaGen Therapeutics
VTGN
$12.3M
$0 ﹤0.01%
+3
New +$106
VTYX
4196
DELISTED
Ventyx Biosciences
VTYX
$0 ﹤0.01%
+17
New +$254
WEAV icon
4197
Weave Communications
WEAV
$547M
$0 ﹤0.01%
+27
New +$130
WEYS icon
4198
Weyco Group
WEYS
$390M
$0 ﹤0.01%
+8
New +$216
WLFC icon
4199
Willis Lease Finance
WLFC
$1.69B
$0 ﹤0.01%
+6
New +$68
WPRT
4200
Westport Fuel Systems
WPRT
$35M
-18,133
Closed -$286K

Similar funds

Credit Suisse's Q2 2022 Portfolio in Review

As of Q2 2022, Credit Suisse held 4,634 positions worth $96.1B, down 18% from $117B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Credit Suisse's Q2 2022 filing shows 1,015 new, 1,222 increased, 1,970 reduced and 108 closed positions. Its largest new stake was iShares U.S. Carbon Transition Readiness Aware Active ETF: 990,000 shares worth $41.3M. The largest sale was iShares China Large-Cap ETF, an estimated $256M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Credit Suisse's largest Q2 2022 buy was iShares U.S. Carbon Transition Readiness Aware Active ETF: 990,000 shares worth $41.3M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $278M increase.
  • Credit Suisse's biggest Q2 2022 reduction was iShares China Large-Cap ETF, cutting an estimated $256M.
  • Credit Suisse fully exited Cerner Corp in Q2 2022, selling an estimated $46M.
  • Credit Suisse's ten largest holdings make up 18% of its $96.1B portfolio in Q2 2022.
  • Credit Suisse opened 1,015 new positions and closed 108 in Q2 2022.
  • Credit Suisse's portfolio value fell 18% quarter-over-quarter to $96.1B.

Based on Credit Suisse's 13F filing for Q2 2022, filed 12 Aug 2022.